Based on the data, the percentage of CD4 + cells were decreased in patients with osteosarcoma tumors compared to patients with GCT (P = 0.017) and healthy subjects (not significant statistically) (Fig. 6G). This evidence concerns the gene CD4 and osteosarcoma.